Here's the recent articles submitted by kevin doe
Articles By kevin doe
With Over 280 Therapies Under Evaluation, The Stem Cell Therapy Market -by Roots Analysis
By: kevin doe
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.(read
entire article)
View : 104 Times
Category : Health
The Stem Cell Therapy Market Is Estimated To Be Worth Usd 8.5 Billion By 2030 - Roots Analysis
By: kevin doe
Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source(read
entire article)
View : 104 Times
Category : Health
More Than 120 Industry Players Are Engaged In Evaluating The Potential Of Over 280 Stem Cell Therapy
By: kevin doe
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options(read
entire article)
View : 105 Times
Category : Health
Global Stem Cells Market: Focus On Clinical Therapies, 2020–2030 – Roots Analysis
By: kevin doe
A detailed assessment of the current market landscape featuring over 280 stem cell-based therapies approved / under clinical development, including information on drug / therapy developer(s) (such as year of establishment,(read
entire article)
View : 108 Times
Category : Health
Microbial Contract Biomanufacturing Market Is Projected To Be Worth Usd 9.3 Billion By 2030 - Roots
By: kevin doe
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly.(read
entire article)
View : 109 Times
Category : Health
Microbial Contract Biomanufacturing Market Is Estimated To Be Worth Usd 9.3 Billion In 2030 - Roots
By: kevin doe
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs(read
entire article)
View : 127 Times
Category : Health
Microbial Contract Biomanufacturing Market Is Projected Grow At An Annualized Rate Of 8.7%
By: kevin doe
Roots Analysis has done a detailed study on “Microbial Contract Biomanufacturing Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities.(read
entire article)
View : 108 Times
Category : Health
Over 115 Companies, Across The World, Claim To Offer A Variety Of Product Development - Roots
By: kevin doe
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems,(read
entire article)
View : 104 Times
Category : Health
Microbial Contract Biomanufacturing Market, 2020-2030 – By Roots Analysis
By: kevin doe
A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment(read
entire article)
View : 108 Times
Category : Health
The Large Volume Wearable Injectors Market Is Estimated To Be Worth Around Usd 600 Million
By: kevin doe
Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries(read
entire article)
View : 106 Times
Category : Health
